Roivant Sciences Ltd.
(ROIV)
undefined
undefined%
At close: undefined
11.66
-0.34%
After-hours Jan 03, 2025, 04:43 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 124.80M | 61.28M | 55.29M | 23.80M | 67.69M |
| Cost of Revenue | 27.96M | 13.13M | 8.97M | 2.06M | 1.13M |
| Gross Profit | 96.83M | 48.15M | 46.32M | 21.74M | 66.56M |
| Operating Income | 4.24B | -1.18B | -1.35B | -1.07B | -532.42M |
| Interest Income | 146.43M | 32.18M | 369.00K | 1.42M | 17.99M |
| Pretax Income | 4.25B | -1.22B | -923.75M | -898.55M | -560.99M |
| Net Income | 4.35B | -1.01B | -845.26M | -809.23M | 1.20B |
| Selling & General & Admin | 675.04M | 600.51M | 775.03M | 259.88M | 335.77M |
| Research & Development | 501.74M | 525.22M | 483.04M | 236.63M | 263.22M |
| Other Expenses | -5.32B | 97.75M | 139.89M | 596.13M | n/a |
| Operating Expenses | -4.13B | 1.22B | 1.40B | 1.09B | 598.98M |
| Interest Expense | 34.78M | 27.97M | 7.04M | 2.81M | 7.68M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | -4.12B | 1.24B | 1.41B | 1.09B | 600.11M |
| Income Tax | 22.22M | 5.19M | 369.00K | 1.69M | 7.12M |
| Shares Outstanding (Basic) | 783.25M | 712.79M | 669.75M | 684.79M | 215.35M |
| Shares Outstanding (Diluted) | 831.05M | 712.79M | 669.75M | 684.79M | 215.35M |
| EPS (Basic) | 5.55 | -1.42 | -1.26 | -1.18 | 5.21 |
| EPS (Diluted) | 5.23 | -1.42 | -1.26 | -1.18 | 5.21 |
| EBITDA | 4.31B | -1.18B | -916.71M | -895.74M | -553.30M |
| Depreciation & Amortization | 22.04M | 18.86M | 5.93M | 175.16M | -20.88M |